First-in-Human trial launches for experimental CAR-T treatment targeting tough kidney cancer
Disease control
Not yet recruiting
This is an early, first-in-human study to test the safety and initial effectiveness of an experimental cell therapy called UCL70805F for patients with advanced kidney cancer. The therapy involves collecting and genetically modifying a patient's own immune cells to target a specif…
Phase: PHASE1 • Sponsor: UTC Therapeutics Inc. • Aim: Disease control
Last updated Apr 13, 2026 20:20 UTC